“The Global qPCR reagents market is poised to reach ~USD 1,893.9 million by 2020 From USD 1,307.0 million in 2015, growing at a CAGR of 7.7%, during 2015 to 2020. North America is expected to hold the largest share of the global qPCR reagents market in 2015. Market growth of qPCR reagents is being propelled by rising patient population base for infectious diseases & genetic disorders, coupled with growing geriatric population, technological advancements in the life sciences sector, increasing public-private investments, funds, and grants for PCR-based research, and the successful completion of the human genome project. However, technical limitations associated with qPCR are restraining the growth of this market.
In this report, the global qPCR reagents market is segmented on the basis detection method (dye-based and probe & primer-based qPCR reagents), packaging type (core kits and mastermixes), end user (hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology companies, clinical research organizations, and forensic laboratories), and application (diagnostic, research, and forensic).
The qPCR core kits segment is expected to account for the larger share of the global qPCR reagents market in 2015, followed by mastermixes. Significant demand growth for qPCR core kits is owing to low prices of core kits (as compared to mastermixes), flexibility offered to end users (as it is best suited for researchers to develop independent reaction protocols), growing private-public funding for life science research, and increasing market availability of qPCR core kits across major countries.
Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the global qPCR reagents market in 2015, followed by Europe. Asia-Pacific is poised to grow at the highest CAGR during the forecast period, owing to factors such as growing incidences of criminal cases across the globe, improving knowledge about human and microbial genome, increasing laboratory automation in forensic laboratories, and various statistical and technical advancements in the field of qPCR.
The global qPCR reagents market is highly competitive, with various global as well as local players. In 2014, the global qPCR reagents devices market was dominated by Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories Inc. (U.S.), and Qiagen N.V. (Netherlands); which together accounted for ~75.0% of the qPCR reagents market. New product launches, agreements, collaborations, partnerships, geographic expansions, mergers, demergers, strategic acquisitions, awareness campaigns, and offering research fund & grants are the major strategies adopted by most market players to achieve growth in the global qPCR reagents market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis such as market share analysis of the top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the qPCR reagents market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms to garner higher market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the qPCR reagents offered by the top 10 players in the global market. The report analyzes the qPCR reagents market by detection method, packaging type, end user, and application across key geographic regions
• Product Development/Innovation: Detailed insights on upcoming qPCR reagents, research and development activities, and new product launches in the market
• Market Development: Comprehensive information on lucrative emerging markets. The report analyzes the markets for various qPCR reagents across key geographic regions
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global qPCR reagents market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global qPCR reagents market
”
“TABLE OF CONTENTS
1 INTRODUCTION 15
1.1 STUDY OBJECTIVES 15
1.2 MARKET DEFINITION 15
1.3 MARKET SCOPE 16
1.3.1 MARKETS COVERED 16
1.3.2 GEOGRAPHIC SCOPE 16
1.3.3 YEARS CONSIDERED FOR THE STUDY 17
1.4 CURRENCY 17
1.5 LIMITATIONS 17
1.6 MARKET STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY DATA 19
2.1.1.1 Key data from secondary sources 19
2.1.2 PRIMARY DATA 19
2.1.2.1 Key data from primary sources 20
2.1.2.2 Breakdown of primaries 20
2.2 FACTOR ANALYSIS 20
2.2.1 INTRODUCTION 20
2.2.2 DEMAND-SIDE ANALYSIS 21
2.2.2.1 Healthcare expenditure patterns 21
2.2.2.2 Rapid growth of aging population 23
2.2.2.3 Incidence and prevalence of cancer 24
2.2.2.4 Birth rate/pregnancies 26
2.2.2.5 Burden of infectious diseases 27
2.2.2.6 Number of clinical, forensic, and research laboratories 29
2.2.3 SUPPLY-SIDE ANALYSIS 30
2.2.3.1 Number of new product launches: qPCR Reagents Vs. Competitive Technologies 30
2.2.3.2 Parent market analysis: Polymerase chain reaction (PCR) market 31
2.3 MARKET SIZE ESTIMATION 32
2.3.1 BOTTOM-UP APPROACH 32
2.3.2 TOP-DOWN APPROACH 33
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 34
2.5 RESEARCH ASSUMPTIONS 35
2.5.1 ASSUMPTIONS 35
3 EXECUTIVE SUMMARY 36
3.1 INTRODUCTION 36
3.2 HISTORY, EVOLUTION, AND CURRENT SCENARIO 36
3.3 FUTURE OUTLOOK 37
3.4 CONCLUSION 40
4 PREMIUM INSIGHTS 41
4.1 GLOBAL qPCR REAGENTS MARKET (2015–2020) 41
4.2 GLOBAL qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD (2015 VS. 2020) 41
4.3 GLOBAL qPCR REAGENTS MARKET SHARE, BY PACKAGING TYPE (2015) 42
4.4 GLOBAL qPCR REAGENTS MARKET SIZE, BY APPLICATION (2015) 42
4.5 GLOBAL qPCR REAGENTS MARKET SIZE, BY END USER (2015 VS. 2020) 43
5 MARKET OVERVIEW 44
5.1 INTRODUCTION 45
5.2 MARKET SEGMENTATION 45
5.3 MARKET DYNAMICS 46
5.3.1 KEY MARKET DRIVERS 47
5.3.1.1 Rising incidence of infectious diseases and genetic disorders 47
5.3.1.2 Growing geriatric population 48
5.3.1.3 Technological advancements 48
5.3.1.4 Increasing public-private investments, funds, and grants 49
5.3.1.5 Successful completion of the human genome project 50
5.3.2 KEY MARKET RESTRAINTS 50
5.3.2.1 Technical limitations associated with qPCR 50
5.3.3 KEY MARKET OPPORTUNITIES 51
5.3.3.1 Growing market penetration in emerging countries 51
5.3.3.2 Shift from plant-derived to genome-based drug discovery 52
5.3.4 KEY MARKET CHALLENGES 52
5.3.4.1 Adoption and implementation of MIQE guidelines for publishing qPCR-based research 52
6 INDUSTRY TRENDS 53
6.1 INTRODUCTION 53
6.2 VALUE CHAIN ANALYSIS 53
6.3 SUPPLY CHAIN ANALYSIS 54
6.4 INDUSTRY TRENDS 55
6.5 PORTER’S FIVE FORCES ANALYSIS 57
6.5.1 THREAT FROM NEW ENTRANTS 57
6.5.2 THREAT FROM SUBSTITUTES 58
6.5.3 BARGAINING POWER OF SUPPLIERS 58
6.5.4 BARGAINING POWER OF BUYERS 58
6.5.5 INTENSITY OF COMPETITIVE RIVALRY 59
7 qPCR REAGENTS MARKET, BY DETECTION METHOD 60
7.1 INTRODUCTION 61
7.2 DYE-BASED qPCR REAGENTS 62
7.3 PROBES AND PRIMER-BASED qPCR REAGENTS 63
8 qPCR REAGENTS MARKET, BY PACKAGING TYPE 64
8.1 INTRODUCTION 65
8.2 qPCR CORE KITS 66
8.3 qPCR MASTERMIXES 66
9 qPCR REAGENTS MARKET, BY END USER 68
9.1 INTRODUCTION 69
9.2 HOSPITALS & DIAGNOSTIC CENTERS 70
9.3 RESEARCH LABORATORIES & ACADEMIC INSTITUTES 71
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 72
9.5 CLINICAL RESEARCH ORGANIZATIONS (CROS) 73
9.6 FORENSIC LABORATORIES 73
10 qPCR REAGENTS MARKET, BY APPLICATION 75
10.1 INTRODUCTION 76
10.2 DIAGNOSTIC APPLICATIONS 77
10.3 RESEARCH APPLICATIONS 78
10.4 FORENSIC APPLICATIONS 79
11 QPCR REAGENTS MARKET, BY REGION 80
11.1 INTRODUCTION 81
11.2 NORTH AMERICA 81
11.2.1 U.S. 84
11.2.2 CANADA 85
11.3 EUROPE 88
11.3.1 GERMANY 90
11.3.2 U.K. 92
11.3.3 FRANCE 93
11.3.4 REST OF EUROPE (RoE) 95
11.4 ASIA-PACIFIC 97
11.4.1 JAPAN 100
11.4.2 CHINA 102
11.4.3 INDIA 104
11.4.4 REST OF ASIA-PACIFIC (RoAPAC) 105
11.5 REST OF THE WORLD (ROW) 107
12 COMPETITIVE LANDSCAPE 109
12.1 OVERVIEW 109
12.2 MARKET SHARE ANALYSIS 110
12.3 COMPETITIVE SCENARIO 111
12.4 RECENT DEVELOPMENTS 112
12.4.1 NEW PRODUCT LAUNCHES AND PRODUCT APPROVALS 112
12.4.2 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 113
12.4.3 MERGERS, DEMERGERS, AND ACQUISITIONS 114
12.4.4 EXPANSION 115
13 COMPANY PROFILE 116
13.1 INTRODUCTION 116
13.1.1 GEOGRAPHIC BENCHMARKING 116
13.1.2 STRATEGIC BENCHMARKING 117
13.1.2.1 Product development and commercialization 117
13.2 THERMO FISHER SCIENTIFIC INC. 119
13.3 BIO-RAD LABORATORIES, INC. 124
13.4 F. HOFFMAN-LA ROCHE LTD. 128
13.5 QIAGEN N.V. 133
13.6 AGILENT TECHNOLOGIES, INC. 138
13.7 TAKARA BIO INC. 141
13.8 AFFYMETRIX, INC. 144
13.9 SIGMA-ALDRICH CORPORATION (A SUBSIDIARY OF MERCK KGAA, GERMANY) 146
13.10 PROMEGA CORPORATION 149
13.11 QUANTA BIOSCIENCES, INC. 150
*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
14 APPENDIX 152
14.1 INSIGHTS OF INDUSTRY EXPERTS 152
14.2 DISCUSSION GUIDE 153
14.3 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE 157
14.4 AVAILABLE CUSTOMIZATIONS 158
14.5 RELATED REPORTS 159
“
“LIST OF TABLES
TABLE 1 qPCR REAGENTS INDUSTRY FOCUSES ON TECHNOLOGICAL INTEGRATION TO DEVELOP ADVANCED PRODUCTS WITH DIVERSE APPLICATION AREAS 56
TABLE 2 qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD,
2013–2020 (USD MILLION) 61
TABLE 3 DYE-BASED qPCR REAGENTS MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 62
TABLE 4 PROBES & PRIMER-BASED qPCR REAGENTS MARKET SIZE, BY REGION,
2013–2020 (USD MILLION) 63
TABLE 5 qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE, 2013–2020 (USD MILLION) 65
TABLE 6 qPCR REAGENTS MARKET SIZE FOR CORE KITS, BY REGION,
2013–2020 (USD MILLION) 66
TABLE 7 qPCR REAGENTS MARKET SIZE FOR MASTERMIXES, BY REGION,
2013–2020 (USD MILLION) 67
TABLE 8 GLOBAL qPCR REAGENTS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 69
TABLE 9 qPCR REAGENTS MARKET SIZE FOR HOSPITALS & DIAGNOSTIC CENTERS,
BY REGION, 2013-2020 (USD MILLION) 70
TABLE 10 qPCR REAGENTS MARKET SIZE FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES, BY REGION, 2013-2020 (USD MILLION) 71
TABLE 11 qPCR REAGENTS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2013-2020 (USD MILLION) 72
TABLE 12 qPCR REAGENTS MARKET SIZE FOR CROS, BY REGION, 2013-2020 (USD MILLION) 73
TABLE 13 qPCR REAGENTS MARKET SIZE FOR FORENSIC LABORATORIES,
BY REGION, 2013-2020 (USD MILLION) 74
TABLE 14 GLOBAL qPCR REAGENTS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 76
TABLE 15 qPCR REAGENTS MARKET SIZE FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2013-2020 (USD MILLION) 77
TABLE 16 qPCR REAGENTS MARKET SIZE FOR RESEARCH APPLICATIONS, BY REGION,
2013-2020 (USD MILLION) 78
TABLE 17 qPCR REAGENTS MARKET SIZE FOR FORENSIC APPLICATIONS, BY REGION,
2013-2020 (USD MILLION) 79
TABLE 18 qPCR REAGENTS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 81
TABLE 19 NORTH AMERICA: qPCR REAGENTS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 82
TABLE 20 U.S.: QPCR REAGENTS MARKET SIZE, BY DETECTION METHOD,
2013-2020 (USD MILLION) 84
TABLE 21 U.S.: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE,
2013-2020 (USD MILLION) 84
TABLE 22 U.S.: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 85
TABLE 23 U.S.: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 85
TABLE 24 CANADA: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD,
2013-2020 (USD MILLION) 86
TABLE 25 CANADA: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE,
2013-2020 (USD MILLION) 86
TABLE 26 CANADA: qPCR REAGENTS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 87
TABLE 27 CANADA: qPCR REAGENTS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 87
TABLE 28 EUROPE: qPCR REAGENTS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 88
TABLE 29 GERMANY: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD,
2013-2020 (USD MILLION) 90
TABLE 30 GERMANY: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE,
2013-2020 (USD MILLION) 91
TABLE 31 GERMANY: qPCR REAGENTS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 91
TABLE 32 GERMANY: qPCR REAGENTS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 91
TABLE 33 U.K.: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD,
2013-2020 (USD MILLION) 92
TABLE 34 U.K.: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE,
2013-2020 (USD MILLION) 92
TABLE 35 U.K.: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 93
TABLE 36 U.K.: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 93
TABLE 37 FRANCE: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD,
2013-2020 (USD MILLION) 94
TABLE 38 FRANCE: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE,
2013-2020 (USD MILLION) 94
TABLE 39 FRANCE: qPCR REAGENTS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 95
TABLE 40 FRANCE: qPCR REAGENTS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 95
TABLE 41 ROE: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD,
2013-2020 (USD MILLION) 96
TABLE 42 ROE: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE,
2013-2020 (USD MILLION) 96
TABLE 43 ROE: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 96
TABLE 44 ROE: qPCR REAGENTS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 97
TABLE 45 ASIA-PACIFIC qPCR REAGENTS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 98
TABLE 46 JAPAN: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD,
2013-2020 (USD MILLION) 100
TABLE 47 JAPAN: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE,
2013-2020 (USD MILLION) 101
TABLE 48 JAPAN: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 101
TABLE 49 JAPAN: qPCR REAGENTS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 101
TABLE 50 CHINA: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD,
2013-2020 (USD MILLION) 102
TABLE 51 CHINA: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE,
2013-2020 (USD MILLION) 103
TABLE 52 CHINA: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 103
TABLE 53 CHINA: qPCR REAGENTS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 103
TABLE 54 INDIA: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD,
2013-2020 (USD MILLION) 104
TABLE 55 INDIA: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE,
2013-2020 (USD MILLION) 104
TABLE 56 INDIA: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 105
TABLE 57 INDIA: qPCR REAGENTS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 105
TABLE 58 ROAPAC: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD,
2013-2020 (USD MILLION) 106
TABLE 59 ROAPAC: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE,
2013-2020 (USD MILLION) 106
TABLE 60 ROAPAC: qPCR REAGENTS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 106
TABLE 61 ROAPAC: qPCR REAGENTS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 107
TABLE 62 ROW: qPCR REAGENTS MARKET SIZE, BY DETECTION METHOD,
2013-2020 (USD MILLION) 107
TABLE 63 ROW: qPCR REAGENTS MARKET SIZE, BY PACKAGING TYPE,
2013-2020 (USD MILLION) 108
TABLE 64 ROW: qPCR REAGENTS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 108
TABLE 65 ROW: qPCR REAGENTS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 108
TABLE 66 NEW PRODUCT LAUNCHES AND PRODUCT APPROVALS, 2012–2015 112
TABLE 67 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2012–2015 113
TABLE 68 MERGERS, DEMERGERS, AND ACQUISITIONS, 2012–2015 114
TABLE 69 GEOGRAPHICAL EXPANSIONS, 2012–2015 115
“
“LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN 18
FIGURE 2 HEALTHCARE EXPENDITURE ACROSS KEY MARKETS, 2000 VS. 2012 22
FIGURE 3 HEALTHCARE SPENDING MATRIX: KEY MARKETS, 2013 22
FIGURE 4 GLOBAL RISE IN PROPORTION OF GERIATRIC POPULATION (2000–2013) 23
FIGURE 5 INCREASE IN AGING POPULATION, BY COUNTRY, 2005 VS. 2010 24
FIGURE 6 GLOBAL BURDEN OF CANCER, BY REGION, 2005–2030 25
FIGURE 7 RISING INCIDENCE OF CANCER ACROSS KEY REGIONS, 2008 VS. 2012 26
FIGURE 8 ANNUAL CRUDE BIRTH RATE ACROSS KEY GLOBAL MARKETS, 2011 27
FIGURE 9 PREVALENCE OF HIV INFECTIONS ACROSS THE GLOBE, BY REGION, 2013 28
FIGURE 10 GLOBAL OUTBREAK OF LEADING INFECTIOUS DISEASES, 1980–2010 29
FIGURE 11 RAPE AND HOMICIDE CASES ACROSS KEY REGIONS, 2003–2012 30
FIGURE 12 qPCR PRODUCTS VS. PCR MARKET: A COMPARATIVE STUDY 31
FIGURE 13 BOTTOM-UP APPROACH 32
FIGURE 14 TOP-DOWN APPROACH 33
FIGURE 15 DATA TRIANGULATION 34
FIGURE 16 ASSUMPTIONS FOR THE RESEARCH STUDY 35
FIGURE 17 NORTH AMERICA IS EXPECTED TO DOMINATE THE DYE-BASED AND PROBE & PRIMER-BASED qPCR REAGENTS MARKETS BY 2020 37
FIGURE 18 NORTH AMERICA IS EXPECTED TO DOMINATE THE qPCR CORE KITS & qPCR MASTERMIXES SEGMENTS BY 2020 38
FIGURE 19 HOSPITALS & DIAGNOSTIC CENTERS SEGMENT WILL CONTINUE TO DOMINATE THE qPCR REAGENTS MARKET IN 2020 38
FIGURE 20 NORTH AMERICA IS EXPECTED TO DOMINATE THE qPCR REAGENTS MARKET DURING THE FORECAST PERIOD 39
FIGURE 21 TOP 3 MARKET PLAYERS TO HOLD ~3/4TH MARKET SHARE OF THE qPCR REAGENTS MARKET (2014) 40
FIGURE 22 ATTRACTIVE GROWTH OPPORTUNITIES IN THE qPCR REAGENTS MARKET 41
FIGURE 23 NORTH AMERICA IS EXPECTED TO DOMINATE THE DYE-BASED AND PROBE & PRIMER-BASED qPCR REAGENTS MARKETS TILL 2020 41
FIGURE 24 U.S. IS EXPECTED TO DOMINATE THE qPCR REAGENTS MARKET IN 2015 42
FIGURE 25 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF KEY qPCR REAGENT APPLICATION SEGMENTS IN 2015 42
FIGURE 26 CHINA AND INDIA TO LEAD THE MARKET DEMAND FOR qPCR REAGENTS AMONG KEY END USERS DURING THE FORECAST PERIOD 43
FIGURE 27 qPCR REAGENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES 46
FIGURE 28 HIV PREVALENCE, BY REGION, 2013 47
FIGURE 29 INCIDENCE OF NEW CANCER CASES WILL BE HIGH AMONG THE GERIATRIC POPULATION 48
FIGURE 30 TRADITIONAL PCR VS. qPCR: A COMPARATIVE STUDY 49
FIGURE 31 PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE—DEVELOPED VS. DEVELOPING COUNTRIES (2010–2012) 51
FIGURE 32 VALUE CHAIN ANALYSIS (2014): MAJOR VALUE IS ADDED DURING THE MANUFACTURING PHASE 54
FIGURE 33 qPCR REAGENTS MARKET: SUPPLY CHAIN (2014) 55
FIGURE 34 PRESENCE OF LARGE NUMBER OF NEW ENTRANTS INCREASES MARKET COMPETITION 57
FIGURE 35 DYE-BASED REAGENTS TO DOMINATE THE qPCR REAGENTS MARKET TILL 2020 61
FIGURE 36 qPCR CORE KITS TO DOMINATE THE qPCR REAGENTS MARKET
REVENUE TILL 2020 65
FIGURE 37 HOSPITALS & DIAGNOSTIC CENTERS TO DOMINATE THE qPCR REAGENTS END-USER MARKET DURING FORECAST PERIOD (2015–2020) 69
FIGURE 38 NORTH AMERICA TO DOMINATE THE qPCR REAGENTS MARKET FOR FORENSIC LABORATORIES 74
FIGURE 39 DIAGNOSTIC APPLICATIONS TO DOMINATE THE qPCR REAGENTS APPLICATION MARKET TILL 2020 76
FIGURE 40 NORTH AMERICA: qPCR REAGENTS MARKET TRENDS (2015-2020) 83
FIGURE 41 EUROPE: qPCR REAGENTS MARKET TRENDS (2015-2020) 89
FIGURE 42 APAC: qPCR REAGENTS MARKET TRENDS (2015-2020) 99
FIGURE 43 PRODUCT DEVELOPMENT & COMMERCIALIZATION WAS ADOPTED BY MOST LEADING PLAYERS DURING 2012-2015 109
FIGURE 44 GLOBAL qPCR REAGENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2014) 110
FIGURE 45 MAJORITY OF LEADING MARKET PLAYERS ARE FOCUSED ON PRODUCT LAUNCHES AND APPROVALS AS THEIR KEY GROWTH STRATEGY 111
FIGURE 46 GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS* (2014) 116
FIGURE 47 LEADING HUMAN QPCR REAGENT MANUFACTURERS FOCUSED ON PRODUCT DEVELOPMENT & COMMERCIALIZATION TO STRENGTHEN THEIR MARKET POSITION 118
FIGURE 48 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 119
FIGURE 49 BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT 124
FIGURE 50 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT 128
FIGURE 51 QIAGEN N.V. : COMPANY SNAPSHOT 133
FIGURE 52 AGILENT TECHNOLOGIES, INC. : COMPANY SNAPSHOT 138
FIGURE 53 TAKARA BIO, INC.: COMPANY SNAPSHOT 141
FIGURE 54 AFFYMETRIX, INC.: COMPANY SNAPSHOT 144
FIGURE 55 SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT 146
“
